Body Protection Compound · PL 14736
The top healing peptide — gut, tendons, joints.
FDA
Reclassified '26
WADA
Not Listed
HALF-LIFE
~4 hours
ROUTE
SubQ injection or oral
SCHEDULE
Daily
In Plain English
BPC-157 is a healing accelerator for tendons, ligaments, and gut tissue. Inject near the injury once daily for 6–8 weeks and expect meaningful improvement by weeks 3–4.
Status & Legality
NATTY?
No Test ExistsNo established test exists for this compound.
FDA
Reclassified '26Compounding pharmacies may prepare under physician oversight.
WADA
Not ListedNot currently on WADA prohibited list.
COMPOUNDING
Category 1Compounding pharmacies may prepare post-2026 reclassification.
PRESCRIBED
Off-label compoundsNot prescribed in conventional medicine.
ROUTE
SubQ injection or oralAdministration via subq injection or oral.
Athletes with nagging tendon or ligament injuries
Anyone recovering from a soft-tissue injury
People dealing with gut issues like IBS, leaky gut, or Crohn's
Active malignancy (theoretical angiogenesis concern)
Pregnancy or nursing — no human safety data
Known hypersensitivity to synthetic peptides
BPC-157 is a synthetic pentadecapeptide derived from a protein found in gastric juice. It promotes angiogenesis, accelerates fibroblast and endothelial cell migration to injury sites, and modulates the nitric oxide pathway. Reclassified by the FDA in early 2026, it remains one of the most studied healing compounds in the research space.
Mild nausea (rare)
Injection site redness
Dizziness at high doses
Vivid dreams
Injecting too far from the injury site — proximity to the target tissue matters significantly
Running indefinitely instead of cycling (6–8 weeks on, then a break)
Dosing under 200 mcg — too low to produce reliable effects
Leaving reconstituted vials at room temperature longer than 7 days
NSAIDs — theoretical compounded anti-inflammatory effect
Anticoagulants — some anecdotal reports of enhanced bleeding reduction
No documented major drug interactions in current literature
250 mcg/day near the injury site for 6 weeks is the protocol most users see meaningful results from. For tendons and ligaments, proximity to the injury consistently outperforms abdominal injection. Don't dose under 200 mcg — it rarely cracks the threshold reliably.
Stats
Sources & Studies
Sikiric P. et al., Curr Pharm Des, 2011